You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
News on CRISPR, gene editing, RNAi in genetics, genomics, and molecular diagnostics.
The CRISPR-based test uses Mammoth's DETECTR BOOST platform and will be compatible with both nasal swab and saliva samples.
The screen homed in on a number of genes involved in cholesterol biosynthesis that, when lost, make cells more resistant to infection.
The Broad Institute's CRISPR paralog screening platform will inform Ideaya's synthetic lethality-based target and biomarker discoveries.
Researchers from the Broad Institute and MIT have used RNA editing and single-cell RNA sequencing to record when RNA molecules were transcribed.
Synthego has developed an off switch for CRISPR by engineering a guide RNA that can be controlled through exposure to UV light.
A 50-year-old cold case was cracked using genetic genealogy, the New York Times reports.
NPR reports that some insect pests are now becoming resistant to Bt crops.
Science reports the US Food and Drug Administration did not consult an outside panel in its approval of remdesivir as a COVID-19 treatment.
In Nature this week: a framework for future human genomic research, PORE-cupine approach to study RNA structure using nanopore sequencing, and more.
Selective breeding represents an efficient approach to increase production of aquaculture species by means of improving traits, such as rapid growth, product quality, and disease resistance.
